Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis

NCT01261403 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment terminated pending additional Phase 1 data

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: PDA001
DRUG: Vehicle Controlled Placebo

Sponsor

Celularity Incorporated

Collaborators

[object Object]